Scarica l'app Stockscreener
6.52
0.15%
0.010
Dopo l'orario di chiusura:
6.51
-0.010
-0.15%
Eupraxia Pharmaceuticals Inc Borsa (EPRX) Ultime notizie
Eupraxia Pharmaceuticals Inc (EPRX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Eupraxia Pharmaceuticals Inc (EPRX) Institutional Confidence - TradingKey
Why Eupraxia Pharmaceuticals Inc stock plummeted yesterday - Wealth Awesome
EPRX|Eupraxia Pharmaceuticals Inc|Price:5.810|Chg%:-0.490 - TradingKey
Eupraxia Pharmaceuticals, Inc. Revenue Breakdown – TSX:EPRX - TradingView
Eupraxia Pharmaceuticals Inc (EPRX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Eupraxia Pharmaceuticals Inc (EPRX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Eupraxia Pharmaceuticals Inc (EPRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TradingKey - TradingKey
Eupraxia Pharmaceuticals Inc (EPRX) Cash Flow - TradingKey
Eupraxia Pharmaceuticals Inc (EPRX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
EPRX|Eupraxia Pharmaceuticals Inc|Price:5.955|Chg%:+0.145 - TradingKey
Eupraxia Pharmaceuticals Inc (EPRX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Eupraxia Pharmaceuticals Inc. (EPRX.TO) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Eupraxia Pharmaceuticals Inc (EPRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
EPRX|Eupraxia Pharmaceuticals Inc|Price:5.910|Chg%:-0.390 - TradingKey
Eupraxia Pharmaceuticals (EPRX) Holds Steady Near Support Amid Low VolumeBullish Percent Index - dars.gov.et
Eupraxia Pharmaceuticals (EPRX) Jefferies Global Healthcare Conference 2026 Summary - Quartr
Eupraxia Pharmaceuticals (EPRX) Q3 2024 earnings summary - Quartr
Eupraxia Pharmaceuticals (EPRX) Bloom Burton & Co. Healthcare Investor Conference 2026 summary - Quartr
LifeSci Capital Maintains Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Maintains Target Price $16 - Moomoo
What's Going On With Eupraxia Pharmaceuticals Inc Stock Tuesday? - Wealth Awesome
Why Eupraxia Pharmaceuticals Inc stock is skyrocketing today - Wealth Awesome
Why Eupraxia Pharmaceuticals Inc stock is rising today - Wealth Awesome
Insider Stock Buying Reaches US$5.58m On Eupraxia Pharmaceuticals - simplywall.st
Why Eupraxia Pharmaceuticals Inc stock is plummeting today - Wealth Awesome
Eupraxia Pharmaceuticals (EPRX) reshapes leadership and expands Vancouver-Seattle hubs - Stock Titan
Why Eupraxia Pharmaceuticals Inc stock is sliding today - Wealth Awesome
Eupraxia names new executives, relocates operations By Investing.com - Investing.com Nigeria
Eupraxia Pharmaceuticals Overhauls Leadership and Operations Ahead of Key EoE Trial Milestone - TipRanks
Eupraxia names new executives, relocates operations - Investing.com
Eupraxia Pharmaceuticals Strengthens Executive Leadership Team to Support Next Phase of Growth - The Manila Times
Eupraxia Pharmaceuticals (NASDAQ: EPRX) adds senior leaders, prepares for Q4 2026 RESOLVE data - Stock Titan
Why Eupraxia Pharmaceuticals Inc stock is tanking today - Wealth Awesome
symbol__ Stock Quote Price and Forecast - CNN
Eupraxia Pharmaceuticals (EPRX) Gains 3.8% as Biotech Sector Shows Resilience – Key Levels to WatchLong Setup Ideas - dars.gov.et
Eupraxia Pharmaceuticals Adds Veteran Drug Developers to Board as Pipeline Advances - TipRanks
Eupraxia Pharmaceuticals (EPRX) adds three drug development and commercialization experts to board - Stock Titan
Eupraxia Pharmaceuticals appoints three directors to board - Investing.com
Eupraxia Pharmaceuticals appoints three directors to board By Investing.com - Investing.com Nigeria
Eupraxia Pharmaceuticals Strengthens Board with Three Industry Leaders in Drug Development and Commercialization - Investing News Network
EPRX Technical Analysis & Stock Price Forecast - Intellectia AI
EPRX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
EPRX Technical Analysis & ETF Price Forecast - Intellectia AI
A3EGRS Forecast — Price Target — Prediction for 2027 - TradingView
Eupraxia Pharmaceuticals (EPRX) Gains Momentum, Testing Key Resistance LevelsCall Flow Alert - dars.gov.et
Eupraxia Pharmaceuticals, Inc. Actuals & Estimates (NASDAQ:EPRX) - TradingView
EPRX Forecast — Price Target — Prediction for 2027 - TradingView
Oppenheimer initiates Eupraxia stock with Outperform rating By Investing.com - Investing.com Nigeria
Eupraxia Pharmaceuticals, Inc. Actuals & Estimates (FWB:X43) - TradingView
Oppenheimer Initiates Eupraxia Pharmaceuticals(EPRX.US) With Buy Rating, Announces Target Price $17 - Moomoo
X43 Forecast — Price Target — Prediction for 2027 - TradingView
Price to sales forward of Eupraxia Pharmaceuticals, Inc. – TSX:EPRX - TradingView
Price to earnings forward of Eupraxia Pharmaceuticals, Inc. – TSX:EPRX - TradingView
Enterprise value to EBITDA forward of Eupraxia Pharmaceuticals, Inc. – TSX:EPRX - TradingView
Eupraxia Pharmaceuticals (EPRX) Slips 2.19% as Stock Tests Key Support at $5.94Cumulative Volume - dars.gov.et
Eupraxia Pharmaceuticals (EPRX) Stock Analysis Report | Financials & Insights - Benzinga
Eupraxia Pharmaceuticals Shareholders Back Board Slate and Auditor at June 18 AGM - TipRanks
0.98%
1.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):